Indian Graves’ disease Market

Indian Graves’ disease Market Size, Share & Trends Analysis Report by Diagnosis (Ultrasound, Imaging Tests, Radioactive Iodine Uptake, and Blood Sample), by Treatment (Anti- Thyroid Medication, Radioactive Iodine Therapy, and Surgery) Forecast Period 2019-2025
    Update Available - Forecast 2024-2030   

Published: Feb 2020 | Report Code: OMR2021025 | Category : Pharmaceuticals | Delivery Format: /

Indian Graves’ disease market is growing at a CAGR of around 6.7% during the forecast period. India is continuously working towards positioning itself as a major region in the technological development and industrialization. There are various large companies in the country which are increasingly focusing on the development of advanced healthcare solutions for humans. The emerging economy such as India has a wide scope in the field of diabetes treatment due to improving government policies, economic reforms, medical tourism, rising diabetes patients, and growth of the diagnostic sector. 

Visit for Global Graves Disease Market Report at: https://www.omrglobal.com/industry-reports/graves-disease-market

Further, Thyroid disorders are considered as one of the most popular diseases that is producing significant burden on the healthcare sector in India and affects the Indian graves’ disease market. According to the Public Health Foundation of India, there is over one-third of the population of the country that suffers from thyroid disorders, accounting to around 32% of Indians suffering from various forms of thyroid disorders. In hyperthyroidism, there are several patients suffering from Grave’s disease and toxic multinodular goiter in India, which are opting surgical management for permanent remission of the disease. Hence, such leads to the demand for the treatment, and in turn fuels the Indian Graves’ disease market growth. 

Furthermore, increasing medical tourism is also expected to accelerate the Indian Grave’s disease market. According to International Brand Equity Foundation (IBEF), Indian healthcare market can increase three-fold to nearly $133.4 billion in 2022. The country is experiencing growth of around 22-25% in medical tourism every year. The healthcare industry was expected to double its size from approximately $3 billion in 2017 to nearly $6 billion in 2018. In addition, medical tourist arrivals in India rose to around 1.1 million in January 2018 from approximately 0.9 million in January 2017. This growth in medical tourism is resulting due to cost-effective medical service and improved healthcare infrastructure in India, which further influences the Indian Graves’ disease market growth.

Research Methodology

The market study of the Indian Graves’ disease market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  1. Indian Graves’ Disease Market Research and Analysis by Diagnosis
  2. Indian Graves’ Disease Market Research and Analysis by Treatment

The Report Covers

  • Comprehensive research methodology of the Indian Graves’ disease market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Indian Graves’ disease market.
  • Insights about market determinants which are stimulating the Indian Graves’ disease market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis 

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. Indian Graves’ Disease Market by Diagnosis

5.1.1. Ultrasound

5.1.2. Imaging Tests

5.1.3. Radioactive Iodine Uptake

5.1.4. Blood Sample

5.2. Indian Graves’ Disease Market by Treatment

5.2.1. Anti- Thyroid Medication

5.2.2. Radioactive Iodine Therapy

5.2.3. Surgery 

6. Company Profiles

6.1. Abbott Laboratories Inc.

6.2. Allergan PLC

6.3. Eli Lilly and Co.

6.4. GlaxoSmithKline PLC

6.5. Johnson & Johnson

6.6. Macleods Pharmaceuticals Ltd.

6.7. Merck & Co. Inc.

6.8. Mylan NV

6.9. Novartis International AG

6.10. Pfizer Inc.

6.11. Sanofi SA

6.12. Takeda Pharmaceutical Co. Ltd.

1. INDIAN GRAVES’ DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)

2. INDIAN GRAVES’ DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

1. INDIAN GRAVES’ DISEASE MARKET SHARE BY DIAGNOSIS, 2018 VS 2025 (%)

2. INDIAN GRAVES’ DISEASE MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)